drugset / Trial / NCT00539578
Treatment of Patients With Anxiety Disorder (0777-022)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to examine the safety and efficacy of MK0777 during treatment for Generalized Anxiety Disorder.
Timeline
- Start
- 2002-09
- Primary completion
- 2003-02
- Completion
- 2003-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK0777 | Small molecule | 3 mg | — |
| Subject | MK0777 | Small molecule | 8 mg | — |